Johnson & Johnson has identified Japan as a key growth market for its pharma business as it outlines its strategic …

Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …
Johnson & Johnson subsidiary McNeil Consumer Healthcare has been officially charged with manufacturing and distributing drugs in violation of federal …
Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …
There seems to be no end to the quality troubles plaguing Johnson & Johnson, with several more recalls to report, …
Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …
The latest flurry of recalls from Johnson & Johnson has prompted additional calls for a wide-ranging investigation of the company’s …
Recalls at Johnson & Johnson are coming thick and fast at the moment. In the latest incident the firm’s troubled …
Johnson & Johnson has been forced to announce yet another recall of over-the-counter medicines manufactured at its Fort Washington facility …
Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …

Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …

In 1906 a psychiatrist working in a Frankfurt asylum became fascinated by the unnamed illness suffered by one of his …
Pepscan Therapeutics, the biotech firm focusing on protein mimicry technology has signed a deal with Tibotec. Netherlands-based Pepscan will use …
Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …
Johnson & Johnson plans to beef up senior management across its three business units as part of a broader programme …